Who owns CONTINEUM THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Contineum Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Contineum Therapeutics stock

Who bought or sold CONTINEUM THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Suvretta Capital Management 2.1M $36M 100% Jun 2024
 View chart
Johnson & Johnson 2.0M $38M 0% Sep 2024
 View chart
Perceptive Advisors 1.5M $29M -3% Sep 2024
 View chart
Franklin Resources 1.4M $24M 131% Sep 2024
 View chart
Versant Venture Management 918k $18M 0% Sep 2024
 View chart
Hillhouse Capital Advisors 669k $13M 0% Sep 2024
 View chart
Samsara BioCapital 589k $11M 0% Sep 2024
 View chart
Vanguard Group 472k $8.3M 100% Jun 2024
 View chart
Altium Capital Management 429k $7.6M 100% Jun 2024
 View chart
BlackRock 405k $7.7M 100% Sep 2024
 View chart
BlackRock 396k $7.0M 100% Jun 2024
 View chart
Baker Bros. Advisors 313k $6.0M 0% Sep 2024
 View chart
Casdin Capital 297k $5.7M 0% Sep 2024
 View chart
Squarepoint Ops 150k $2.6M 100% Jun 2024
 View chart
Geode Capital Management 129k $2.5M -18% Sep 2024
 View chart
State Street Corporation 92k $1.6M 100% Jun 2024
 View chart
Saturn V Capital Management 73k $1.3M 100% Jun 2024
 View chart
Driehaus Capital Management 67k $1.3M 0% Sep 2024
 View chart
Northern Trust 63k $1.2M 100% Sep 2024
 View chart
Charles Schwab Investment Management 43k $829k -16% Sep 2024
 View chart
Board of Trustees of The Leland Stanford Junior University 39k $744k 0% Sep 2024
 View chart
Bank of New York Mellon 14k $271k -30% Sep 2024
 View chart
Morgan Stanley 12k $209k 100% Jun 2024
 View chart
Hrt Financial 11k $213k 100% Sep 2024
 View chart
Winton Capital 11k $213k 100% Sep 2024
 View chart
Barclays 8.3k $158k 249% Sep 2024
 View chart
Bnp Paribas Arbitrage, Snc 6.7k $129k 1249% Sep 2024
 View chart
Rhumbline Advisers 6.0k $116k -10% Sep 2024
 View chart
Bank of America Corporation 5.6k $107k 25% Sep 2024
 View chart
Citigroup 4.9k $93k 219% Sep 2024
 View chart
Mirae Asset Global Etfs Holdings 3.1k $59k 100% Sep 2024
 View chart
Jpmorgan Chase & Co 2.5k $48k -16% Sep 2024
 View chart
Wells Fargo & Company 2.1k $40k -19% Sep 2024
 View chart
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 1.3k $25k 0% Sep 2024
 View chart
Royal Bank of Canada 1.2k $19k 63% Sep 2024
 View chart
Summit Investment Advisors 680.00 $13k 0% Sep 2024
 View chart
New York State Common Retirement Fund 600.00 $11k -89% Sep 2024
 View chart
California State Teachers Retirement System 420.00 $8.0k -17% Sep 2024
 View chart
Amalgamated Bank 240.00 $5.0k 0% Sep 2024
 View chart
Harbor Capital Advisors 168.00 $3.0k 100% Sep 2024
 View chart
Tower Research Capital 94.00 $1.7k 100% Jun 2024
 View chart
NISA Investment Advisors 29.00 $554.999100 100% Sep 2024
 View chart
CWM 28.00 $1.0k 100% Sep 2024
 View chart
Sterling Capital Management 13.00 $248.999400 100% Sep 2024
 View chart

Who sold out of Contineum Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Jun 2024 128k $2.3M
Invesco Jun 2024 11k $190k
Sandia Investment Management Jun 2024 5.0k $88k
MetLife Investment Advisors Jun 2024 1.9k $34k